Barclays Cuts Sotera Health (NASDAQ:SHC) Price Target to $12.00

Sotera Health (NASDAQ:SHC) had its price objective decreased by Barclays from $16.00 to $12.00 in a research note issued to investors on Thursday,Benzinga reports. Barclays currently has an overweight rating on the stock.

Sotera Health Stock Down 0.8 %

SHC stock opened at $10.51 on Thursday. The stock has a market capitalization of $2.98 billion, a price-to-earnings ratio of 42.04 and a beta of 1.88. The company has a 50-day moving average of $12.15 and a two-hundred day moving average of $13.52. Sotera Health has a 52-week low of $9.53 and a 52-week high of $17.08. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61.

Institutional Trading of Sotera Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. FMR LLC boosted its position in shares of Sotera Health by 259.9% in the third quarter. FMR LLC now owns 32,483 shares of the company’s stock valued at $542,000 after acquiring an additional 23,457 shares during the period. Quantinno Capital Management LP raised its stake in Sotera Health by 59.4% during the 3rd quarter. Quantinno Capital Management LP now owns 29,217 shares of the company’s stock valued at $488,000 after purchasing an additional 10,885 shares during the last quarter. State Street Corp boosted its holdings in Sotera Health by 18.5% in the 3rd quarter. State Street Corp now owns 4,126,806 shares of the company’s stock valued at $68,918,000 after purchasing an additional 644,236 shares during the period. Public Employees Retirement System of Ohio grew its position in Sotera Health by 14.3% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 54,706 shares of the company’s stock worth $914,000 after purchasing an additional 6,826 shares during the last quarter. Finally, Barclays PLC increased its holdings in shares of Sotera Health by 169.8% during the 3rd quarter. Barclays PLC now owns 473,597 shares of the company’s stock worth $7,909,000 after purchasing an additional 298,085 shares during the period. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.